Numerous studies have described Syk abnormalities in BCR-mediated signaling in B cells and Syk inhibition in the progression of glomerulonephritis in SLE (45), but there is little information regarding the role of FcγR-mediated signaling in the progression of spleen inflammation and immune responses. The gene discussed is BCR; the disease is systemic lupus erythematosus.